Cargando…

COVID19 antibody detection using lateral flow assay tests in a cohort of convalescent plasma donors

OBJECTIVE: COVID19 has caused a global and ongoing pandemic. The need for population seroconversion data is apparent to monitor and respond to the pandemic. Using a lateral flow assay (LFA) testing platform, the seropositivity in 63 New York Blood Center (NYBC) Convelescent Plasma (CP) donor samples...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ragnesola, Brett, Jin, Daniel, Lamb, Christopher C., Shaz, Beth H., Hillyer, Christopher D., Luchsinger, Larry L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407441/ https://www.ncbi.nlm.nih.gov/pubmed/32762746 http://dx.doi.org/10.1186/s13104-020-05212-0

Ejemplares similares

Earlier the better: convalescent plasma
por: Tobian, Aaron A.R., et al.
Publicado: (2020)

COVID-19 convalescent plasma
por: Tobian, Aaron A. R., et al.
Publicado: (2022)

Dynamics of antibodies to SARS‐CoV‐2 in convalescent plasma donors
por: Steenhuis, Maurice, et al.
Publicado: (2021)

Antibody indexes in COVID-19 convalescent plasma donors: Unanswered questions
por: Bonetti, Tatiana Carvalho de Souza, et al.
Publicado: (2021)

Assessment of serological assays for identifying high titer convalescent plasma
por: Farnsworth, Christopher W., et al.
Publicado: (2021)

Dynamics of anti-SARS-CoV-2 antibodies in repeat convalescent plasma donors
por: Franchini, Massimo, et al.
Publicado: (2021)

Recruitment Strategy for Potential COVID-19 Convalescent Plasma Donors
por: Andersen, Kylie J., et al.
Publicado: (2020)

Appropriate selection of convalescent plasma donors for COVID-19
por: Tedder, Richard S, et al.
Publicado: (2021)

Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma
por: Vazquez, Sara E., et al.
Publicado: (2021)

Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program
por: Wendel, Silvano, et al.
Publicado: (2020)

Associations Between Symptoms, Donor Characteristics and IgG Antibody Response in 2082 COVID-19 Convalescent Plasma Donors
por: Vinkenoog, Marieke, et al.
Publicado: (2022)

Assessment of serological assays for identifying high titer convalescent plasma
por: Farnsworth, Christopher W., et al.
Publicado: (2021)

The predictors of high titer of anti-SARS-CoV-2 antibody of convalescent plasma donors
por: Wardhani, Shinta Oktya, et al.
Publicado: (2021)

P1622: ANTIPHOSPHOLIPID ANTIBODIES IN CONVALESCENT PLASMA OF DONORS RECOVERED FROM MILD COVID-19
por: Blickstein, D., et al.
Publicado: (2022)

Correlation between Clinical Characteristics and Antibody Levels in COVID-19 Convalescent Plasma Donor Candidates
por: Uzun, Günalp, et al.
Publicado: (2023)

Lateral ST-elevation myocardial infarction after donation of COVID-19 convalescent plasma in a naïve donor
por: Shams, Pirbhat, et al.
Publicado: (2021)

Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formats
por: Nesbitt, Daniel J., et al.
Publicado: (2021)

Nanoelectrokinetic-assisted lateral flow assay for COVID-19 antibody test
por: Kim, Cheonjung, et al.
Publicado: (2022)

No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity
por: Nomoto, Hidetoshi, et al.
Publicado: (2021)

Ropner Convalescent Home, Stockton-On-Tees
por: Hillyer, C. M.
Publicado: (1898)

Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
por: Klein, Sabra, et al.
Publicado: (2020)

SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors
por: Benner, Sarah E, et al.
Publicado: (2020)

Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in Egyptian Convalescent Plasma Donors
por: Gomaa, Mokhtar R., et al.
Publicado: (2020)

HLA Antibody Rates Are Not Increased in a Regional Group of Male COVID-19 Convalescent Plasma Donors
por: Juskewitch, Justin E., et al.
Publicado: (2021)

Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and “Reopening”
por: Jin, Daniel K., et al.
Publicado: (2021)

Functional Antibodies in COVID-19 Convalescent Plasma
por: Herman, Jonathan D., et al.
Publicado: (2021)

Predicting the efficacy of COVID-19 convalescent plasma donor units with the Lumit Dx anti-receptor binding domain assay
por: Janaka, Sanath Kumar, et al.
Publicado: (2021)

Retrospective comparison of convalescent plasma with continuing high‐dose methylprednisolone treatment in SARS patients
por: Soo, Y. O. Y., et al.
Publicado: (2004)

Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone
por: Tedder, Richard S., et al.
Publicado: (2018)

CHALLENGES IN THE PRODUCTION OF COVID-19 CONVALESCENT PLASMA – ANALYSIS OF DONOR RECRUITMENT
por: Sekiya, E.J., et al.
Publicado: (2020)

Challenges in the production of COVID-19 convalescent plasma- analysis of donor recruitment
por: Sekiya, Eliseo Joji, et al.
Publicado: (2021)

COVID-19 vaccination: The impact on the selection criteria of the convalescent plasma donors
por: Bansal, N., et al.
Publicado: (2021)

Detection of Shiga Toxins by Lateral Flow Assay
por: Ching, Kathryn H., et al.
Publicado: (2015)

Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 Patients
por: Luchsinger, Larry L., et al.
Publicado: (2020)

Lateral flow assays
por: Koczula, Katarzyna M., et al.
Publicado: (2016)

Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients
por: Luchsinger, Larry L., et al.
Publicado: (2020)

The Management of Convalescence
Publicado: (1907)

Longitudinal SARS-CoV-2 Seroconversion Course and Antibody Levels by Blood Groups in Convalescent Plasma Donors in Turkey
por: Karaca, Aziz, et al.
Publicado: (2021)

Antibody response against SARS-CoV-2 in convalescent plasma donors: Can we predict subjects’ eligibility?
por: Prudente, Tiago Paiva, et al.
Publicado: (2022)

The Quality of Anti-SARS-CoV-2 T Cell Responses Predicts the Neutralizing Antibody Titer in Convalescent Plasma Donors
por: Kroemer, Marie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dvdtid3g6p5tl7mtu7eqaksbcs